The recent meta-analyses indicated that in patients with high TMAO plasma level, the incidence of major adverse cardiovascular events was significantly higher compared with patients with low TMAO levels [67], and that all-cause mortality increased by 7.6% per each 10 mol/L increment of TMAO [68]
Red flags include claims of guaranteed weight loss percentages, promises of appetite suppression without medical oversight, and sourcing recommendations that bypass licensed healthcare providers
This 30-minute podcast will share insights from a recent expert consensus panel publication: Nutrition and Lifestyle Supportive Care Recommendations for Management of Obesity with GLP-1 based Therapies: An expert Consensus statement using a modified Delphi Approach. Co-author Linda Gigliotti will outline priorities for nutritional management of patients treated with GLP-1 based therapies, describe dietary strategies to help manage common gastrointestinal side effects, and identify lifestyle interventions highlighted by the panel to help optimize outcomes throughout the weight loss and weight maintenance journey
Ipamorelins high GHSR selectivity minimizes cortisol and prolactin effects seen with older secretagogues
Avoid high-fat, greasy, or heavily spiced foods during the first few weeks
**The 12 mg dose requires reconstituting 2 vials (each with 1.0 mL)
